Asia Summer School 2026: China Healthcare

Research evidence excerpt

Asia Summer School 2026: China Healthcare

e information in Morgan Stanley Research is being disseminated by Morgan Stanley Saudi Arabia, regulated by the Capital Market Authority in the Kingdom of Saudi Arabia, and

is directed at Sophisticated investors only.

Morgan Stanley Hong Kong Securities Limited is the liquidity provider/market maker for securities of Akeso, Inc., Alibaba Health Information Technology, CSPC Pharmaceutical Group, Fosun Pharmaceutical, Innovent Biologics Inc, JD Health International Inc.,

MicroPort Scientific Corp., Ping An Healthcare and Technology, RemeGen Co., Ltd., Sino Biopharmaceutical, WuXi AppTec Co Ltd, WuXi Biologics Cayman Inc, WuXi XDC Cayman Inc. listed on the Stock Exchange of Hong Kong Limited. An updated list can

be found on HKEx website: http://www.hkex.com.hk.

The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co. International plc (DIFC Branch), regulated by the Dubai Financial Services Authority (the DFSA) or by Morgan Stanley & Co. International plc (ADGM Branch), regulated

by the Financial Services Regulatory Authority Abu Dhabi (the FSRA), and is directed at Professional Clients only, as defined by the DFSA or the FSRA, respectively. The financial products or financial services to which this research relates will only be made

available to a customer who we are satisfied meets the regulatory criteria of a Professional Client. A distribution of the different MS Research ratings or recommendations, in percentage terms for Investments in each sector covered, is available upon request

from your sales representative.

The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co.